Litcius/Paper detail

Models for calcific aortic valve disease in vivo and in vitro

Zijin Zhu, Zhirong Liu, Donghui Zhang, Li Li, Jianqiu Pei, Lin Cai

2024Cell Regeneration12 citationsDOIOpen Access PDF

Abstract

Calcific Aortic Valve Disease (CAVD) is prevalent among the elderly as the most common valvular heart disease. Currently, no pharmaceutical interventions can effectively reverse or prevent CAVD, making valve replacement the primary therapeutic recourse. Extensive research spanning decades has contributed to the establishment of animal and in vitro cell models, which facilitates a deeper understanding of the pathophysiological progression and underlying mechanisms of CAVD. In this review, we provide a comprehensive summary and analysis of the strengths and limitations associated with commonly employed models for the study of valve calcification. We specifically emphasize the advancements in three-dimensional culture technologies, which replicate the structural complexity of the valve. Furthermore, we delve into prospective recommendations for advancing in vivo and in vitro model studies of CAVD.

Topics & Concepts

CalcificationHeart valveAortic valveMedicineDiseaseIn vivovalvular heart diseaseValve replacementPathologyCardiologyBiologyBiotechnologyStenosisCardiac Valve Diseases and TreatmentsAortic Disease and Treatment ApproachesAortic aneurysm repair treatments
Models for calcific aortic valve disease in vivo and in vitro | Litcius